Literature DB >> 22367065

Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.

Tatsuhiro Tsujimoto1, Hideto Kawaratani, Toshiyuki Kitazawa, Masahito Uemura, Hiroshi Fukui.   

Abstract

BACKGROUND: Over-proliferation and bacterial translocation of Gram-negative bacilli within the intestinal flora, and increased portal venous levels of endotoxins, are involved in nonalcoholic steatohepatitis (NASH). AIM: To evaluate the innate immune response in the small intestine and liver using the rat NASH model.
METHODS: We produced the NASH model by administering a choline-deficient amino acid-defined diet to F344 rats. We analyzed the serum and liver tissue to assess the effects of innate immune reactivity in this NASH model.
RESULTS: Significant increases were detected in serum ALT levels and in the portal venous serum and whole-liver levels of TNF-α and IFN-γ in the NASH group. Strong Sirius red staining and TNF-α immune staining were seen in the NASH group, and real-time PCR revealed significantly increased expression of TNF-α and TLR4 mRNA in the NASH group. Higher TNF-α levels were detected in the Kupffer cells isolated culture supernatant in the NASH group than in the control group. Immune staining of the ileal tissue specimens resulted in greater staining of TNF-α, TLR4, and macrophage/dendritic cells, mainly in the submucosa, in the NASH group than in the control group.
CONCLUSIONS: In the small intestine and liver of the rat NASH model, the possibility that enhancement of the innate immune response, mediated by the TLR4 signal, led to increased production of TNF-α was suggested. This interaction between the small intestine and liver may be involved in the onset and progression of NASH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367065     DOI: 10.1007/s10620-012-2073-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.

Authors:  T Tsujimoto; S Kuriyama; M Yamazaki; Y Nakatani; H Okuda; H Yoshiji; H Fukui
Journal:  Int J Oncol       Date:  2001-01       Impact factor: 5.650

2.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay.

Authors:  H Fukui; B Brauner; J C Bode; C Bode
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

3.  Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.

Authors:  Sabine Wagnerberger; Astrid Spruss; Giridhar Kanuri; Valentina Volynets; Carolin Stahl; Stephan C Bischoff; Ina Bergheim
Journal:  Br J Nutr       Date:  2011-10-10       Impact factor: 3.718

4.  Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.

Authors:  K Tomita; G Tamiya; S Ando; K Ohsumi; T Chiyo; A Mizutani; N Kitamura; K Toda; T Kaneko; Y Horie; J-Y Han; S Kato; M Shimoda; Y Oike; M Tomizawa; S Makino; T Ohkura; H Saito; N Kumagai; H Nagata; H Ishii; T Hibi
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

5.  Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.

Authors:  S Kubo; T Rodriguez; M S Roh; C Oyedeji; M M Romsdahl; K Nishioka
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

6.  Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.

Authors:  Hideto Kawaratani; Tatsuhiro Tsujimoto; Toshiyuki Kitazawa; Hitoshi Yoshiji; Masahito Uemura; Hiroshi Fukui
Journal:  J Gastroenterol Hepatol       Date:  2011-04       Impact factor: 4.029

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Hitoshi Yoshiji; Masao Fujimoto; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

9.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

10.  Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Toshiko Hirai; Hajime Ohishi; Mitsuteru Kitade; Hitoshi Yoshiji; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

View more
  11 in total

Review 1.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Suvarthi Das; Firas Alhasson; Varun Chandrashekaran; Gregory Michelotti; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-30       Impact factor: 4.052

3.  Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle.

Authors:  Julia Wattacheril; Kristie L Rose; Salisha Hill; Christian Lanciault; Clark R Murray; Kay Washington; Brandon Williams; Wayne English; Matthew Spann; Ronald Clements; Naji Abumrad; Charles Robb Flynn
Journal:  Hepatol Res       Date:  2017-04-19       Impact factor: 4.288

Review 4.  Implications of microbiota and bile acid in liver injury and regeneration.

Authors:  Hui-Xin Liu; Ryan Keane; Lili Sheng; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2015-08-07       Impact factor: 25.083

5.  A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Tommy Pacana
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

6.  Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease.

Authors:  Monika Rau; Ateequr Rehman; Marcus Dittrich; Albert K Groen; Heike M Hermanns; Florian Seyfried; Niklas Beyersdorf; Thomas Dandekar; Philip Rosenstiel; Andreas Geier
Journal:  United European Gastroenterol J       Date:  2018-09-30       Impact factor: 4.623

Review 7.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

Review 8.  Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Ryota Masuzaki; Mitsuhiko Moriyama; Masao Omata
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

Review 9.  Gut Microbiota and Host Reaction in Liver Diseases.

Authors:  Hiroshi Fukui
Journal:  Microorganisms       Date:  2015-10-28

10.  Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis.

Authors:  Jian Zhang; Chunying Wang; Ji Wang; Fengchi Zhang
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.